The novel treatment of the medication represents a significant development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide358686.bloggadores.com/40773686/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment